Literature DB >> 23602824

Kinetics of intrahepatic covalently closed circular DNA and serum hepatitis B surface antigen during antiviral therapy for chronic hepatitis B: lessons from experimental and clinical studies.

Fabien Zoulim, Barbara Testoni, Fanny Lebossé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23602824     DOI： 10.1016/j.cgh.2013.04.010

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  10 in total

1.  Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy.

Authors:  L Luckenbaugh; K M Kitrinos; W E Delaney; J Hu
Journal:  J Viral Hepat       Date:  2014-11-14       Impact factor: 3.728

Review 2.  Antiviral therapies and prospects for a cure of chronic hepatitis B.

Authors:  Fabien Zoulim; David Durantel
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

Review 3.  Prevention of hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Conrado M Fernández-Rodríguez; María Luisa Gutiérrez-García
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

4.  Quantification of serum hepatitis B surface antigen in predicting the response of pegylated interferon alfa-2a in HBeAg-positive chronic hepatitis B with prior lamivudine exposure.

Authors:  Min Weng; Wei-Zheng Zeng; Xiao-Ling Wu; Yong Zhang; Ming-De Jiang; Zhao Wang; De-Jiang Zhou; Xuan He
Journal:  Virol J       Date:  2013-09-06       Impact factor: 4.099

5.  Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs.

Authors:  Jing Huang; Ka Zhang; Wenli Chen; Jinyao Liao; Xiaodan Luo; Ren Chen
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

Review 6.  Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.

Authors:  Jianming Hu; Kuancheng Liu
Journal:  Viruses       Date:  2017-03-21       Impact factor: 5.048

Review 7.  Meeting the Challenge of Eliminating Chronic Hepatitis B Infection.

Authors:  Peter A Revill; Capucine Penicaud; Christian Brechot; Fabien Zoulim
Journal:  Genes (Basel)       Date:  2019-04-01       Impact factor: 4.096

8.  Treatment with the Immunomodulator AIC649 in Combination with Entecavir Produces Antiviral Efficacy in the Woodchuck Model of Chronic Hepatitis B.

Authors:  Kyle E Korolowicz; Manasa Suresh; Bin Li; Xu Huang; Changsuek Yon; Xuebing Leng; Bhaskar V Kallakury; Robin D Tucker; Stephan Menne
Journal:  Viruses       Date:  2021-04-09       Impact factor: 5.048

Review 9.  Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus.

Authors:  Teresa Broquetas; José A Carrión
Journal:  Hepat Med       Date:  2022-07-29

10.  Correlation between hepatic human males absent on the first (hMOF) and viral persistence in chronic hepatitis B patients.

Authors:  Liwen Chen; Chuanwu Zhu; Fengdi Li; Yun Wang; Rebecca Bao; Zhujun Cao; Xiaogang Xiang; Lei Yan; Lanyi Lin; Gangde Zhao; Qing Xie; Shisan Bao; Hui Wang
Journal:  Cell Biosci       Date:  2018-02-20       Impact factor: 7.133
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.